“ Chronic Hepatitis C Treatment for Genotype 2 or 3 in Brazil: Cost Effectiveness Analysis of Peginterferon Plus Ribavirin As First Choice Treatment ”. 2014. Brazilian Journal of Pharmaceutical Sciences 50 (2): 345-52. https://doi.org/10.1590/S1984-82502014000200014.